NanoViricides, Inc.
NNVC
$1.26
$0.010.80%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.13% | -58.83% | 34.01% | -8.91% | -21.19% |
| Total Depreciation and Amortization | 3.49% | 3.44% | 0.90% | 0.90% | 1.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.62% | -15.64% | -76.64% | -9.26% | -7.18% |
| Change in Net Operating Assets | -359.09% | -48.55% | -62.05% | -17.53% | 49.62% |
| Cash from Operations | -27.45% | -121.46% | 1.15% | -11.82% | -22.74% |
| Capital Expenditure | 100.00% | -463.86% | -3,676.92% | 24.79% | 87.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -463.86% | -3,676.92% | 24.79% | 87.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.32% | 21.06% | 202.62% | -10.61% | -17.33% |